Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease

 
Το τεκμήριο παρέχεται από τον φορέα :

Αποθετήριο :
Annals of Gastroenterology
δείτε την πρωτότυπη σελίδα τεκμηρίου
στον ιστότοπο του αποθετηρίου του φορέα για περισσότερες πληροφορίες και για να δείτε όλα τα ψηφιακά αρχεία του τεκμηρίου*
κοινοποιήστε το τεκμήριο




2007 (EL)

Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease (EN)

P. Cherakakis, J.K. Triantafillidis,

SUMMARY In this review the current aspects concerning the application of leukocytapheresis in patients with inflammatory bowel disease are briefly discussed. Leukocytapheresis has already been applied in patients suffering mainly from diseases affecting the immunological balance. The procedure has recently been tried in patients with ulcerative colitis and Crohn’s disease as well, with promising results. Leukocytapheresis is gaining in interest as a therapeutic procedure of the near future, because it removes - in a short time- a number of immunologically active cells, which are well known to actively participate in the inflammatory cascade, leading to tissue damage. However, further studies are needed in order to better clarify the role of leukocytapheresis in the maintenance treatment of patients with inflammatory bowel disease, either alone, or in combination with drugs of known efficacy in IBD. Key words: Apheresis, Leucocytapheresis, Inflammatory bowel disease, Ulcerative colitis, Crohn’s disease (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion


Αγγλική γλώσσα

2007-03-19


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 16, No 2 (2003) (EN)




*Η εύρυθμη και αδιάλειπτη λειτουργία των διαδικτυακών διευθύνσεων των συλλογών (ψηφιακό αρχείο, καρτέλα τεκμηρίου στο αποθετήριο) είναι αποκλειστική ευθύνη των αντίστοιχων Φορέων περιεχομένου.